Opinion: Our unsustainable health-care system

Article

Health care in America is far too expensive; reform will require sacrifices from doctors, hospitals, lawyers, patients, and insurance companies.

American physicians-indeed, all participants in the US health-care system-have been trained and have practiced their profession during the most massive transfer of resources into a single sector, health care, than any society has seen outside war." -Richard Lamm.1

US health-care spending is unsustainable

One could argue that if the American people want to spend a fifth of their wealth on health care, why shouldn't they? There are two problems with this line of reasoning:

1. None of our industrial competitors burden their economies or industries with such costs; and

2. We are not getting our money's worth.

In 1980, the United States had the highest level of health-care spending per capita in the world. Over the next 25 years, the share of GDP devoted to health care in the US has grown from 8.8% in 1980 to just over 16% in 2007. More than a third of these costs were borne by US companies who provide insurance for 60% of the population. By contrast, given their nations' national health systems, virtually none of our foreign industrial competitors are so burdened. And while we now spend 50% to 100% more than other industrialized nations on health care, we rank 37th (behind Costa Rica) in terms of the performance of our health-care delivery system, according to the World Health Organization.2 The WHO's assessment is based on five indicators: overall population health, health disparities, health system responsiveness (i.e., patient satisfaction and how well the system performs), universal access, and financial burden. We badly lag in each category.

Recent Videos
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Lauren Streicher, MD
JoAnne Pinkerton, MD, FACOG, NCMP
Nannette Santoro, MD
Lauren Streicher, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.